On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)

NCT01670162 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration
Pigment Epithelial Detachment

Interventions

DRUG: Aflibercept

Sponsor

Tennessee Retina

Collaborators

[object Object]